Evaluation of anti-fatigue effect on the single intake of egg white peptide

Evaluation of anti-fatigue effect on the single intake of egg white peptide - Egg white peptide trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220395

Enrollment

Registered

2018-10-26

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue

Interventions

Intervention type: Name of intervention:Egg white peptide Dose form / Japanese Medical Device Nomenclature:JELLY Route of administration / Site of application:ORAL Dose per administration:4 protein g/

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: athlete

Exclusion criteria

Exclusion criteria: Egg allergy

Design outcomes

Primary

Measure	Time frame
Fatigue, Oxidative stress, Antioxidant ability	—

Countries

Japan

Contacts

Public ContactMariko Oe

Kewpie Corporation

mariko_oe@kewpie.co.jp+81-3-5384-7759

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026